Big Movers: Agilysys Inc. (NASDAQ:AGYS), Apple Inc. (NASDAQ:AAPL), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Criteo SA (NASDAQ:CRTO), Parkway Properties Inc. (NYSE:PKY)

Agilysys Inc. (NASDAQ:AGYS) reported operating results for its fiscal 2016 first quarter. Total net revenue was $27.5 million, compared to total net revenue of $23.7 million in the comparable prior-year period.
Recurring revenues (which are comprised of support, maintenance and subscription services) were $14.9 million, or 54% of total net revenue, compared to $13.8 million, or 58% of total net revenue, for the same period in fiscal 2015. Agilysys Inc. (NASDAQ:AGYS) belongs to Technology sector. Its net profit margin is -11.00% and weekly performance is 20.17%. On last trading day company shares ended up $9.89. Agilysys Inc. (NASDAQ:AGYS) distance from 50-day simple moving average (SMA50) is 7.83%.

Apple Inc. (NASDAQ:AAPL) is the king of premium tech products and its success in the high-end tech market remains unrivaled. In April, Apple opened up pre-orders of the Apple Watch along with the launch of a new MacBook. The new laptop sold out on the very day its order opened, a clear statement that users are smitten with the new MacBook. Apple Inc. (NASDAQ:AAPL) belongs to Consumer Goods sector. Its net profit margin is 22.60% and weekly performance is -6.17%. On last trading day company shares ended up $115.40. Apple Inc. (NASDAQ:AAPL) distance from 50-day simple moving average (SMA50) is -8.79%.

Mylan NV (NASDAQ:MYL) was recently successful in untangling itself from aggressive takeover attempts by Israeli generic drug-maker Teva Pharmaceuticals Industries Ltd. (ADR) (NYSE:TEVA). The development frees up Mylan to pursue its own takeover target Perrigo Company plc (NYSE:PRGO), with a renewed ambition and recently earned European approval to move forward with the proposed transaction. In April, Teva initially extended a $40 billion unsolicited bid for Mylan, another strong competitor in the generic drugs industry. On 05 August, Teva Pharmaceutical Industries Limited (NYSE:TEVA) shares moved up 0.71% and was closed at $71.19. TEVA EPS growth in last 5 year was 9.80%. Teva Pharmaceutical Industries Limited (NYSE:TEVA) year to date (YTD) performance is 25.23%.

Criteo SA (NASDAQ:CRTO) announced its financial results for the second quarter ended June 30, 2015. Revenue in the second quarter 2015 increased 64% (or 51% at constant currency1) to €271 million, compared with €165 million in the second quarter 2014.Criteo SA (NASDAQ:CRTO) ended the last trading day at $47.81. Company weekly volatility is calculated as 6.88% and price to cash ratio as 9.25. Criteo SA (NASDAQ:CRTO) showed a weekly performance of -8.69%.

Parkway Properties (NYSE:PKY) posted its earnings results on Monday. The real estate investment trust reported $0.33 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.32 by $0.01. During the same quarter in the previous year, the company posted $0.35 earnings per share.Parkway Properties Inc. (NYSE:PKY) shares moved down -1.13% in last trading session and ended the day at $17.45. PKY Gross Margin is 56.50% and its return on assets is 1.50%. Parkway Properties Inc. (NYSE:PKY) quarterly performance is 5.66%.

Leave a Reply

Your email address will not be published. Required fields are marked *